Arvind Arora
Impact in
Papers in
- Co-authors
- Srinivasan Madhusudan (20 shared papers)Ian Ogilvie Ellis (14 shared papers)Paul M. Moseley (13 shared papers)Stephen Y.T. Chan (13 shared papers)Graham Ball (10 shared papers)Christina J. Perry (9 shared papers)Andrew R. Green (12 shared papers)Emad A. Rakha (12 shared papers)
- Journals
- Molecular Oncology (3 papers)Oncotarget (3 papers)International Orthopaedics (2 papers)Molecular Cancer Therapeutics (2 papers)Cancers (2 papers)
- Partner nations
- United KingdomUnited StatesIndia
In The Last Decade
Arvind Arora
44 papers receiving 1.9k citations
Arvind Arora's Hit Papers
Peers
Comparison fields: 5 of 116
- Pharmacy 124
- Oncology 541
- Clinical Psychology 411
- Cancer Research 199
- Surgery 556
Countries citing papers authored by Arvind Arora
This map shows the geographic impact of Arvind Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind Arora more than expected).
Fields of papers citing papers by Arvind Arora
This network shows the impact of papers produced by Arvind Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind Arora. The network helps show where Arvind Arora may publish in the future.
Co-authors
The 25 scholars most cited alongside Arvind Arora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial Hit paper breakdown → | 2021 | 546 |
| 2 | The Attractive Female Body Weight and Female Body Dissatisfaction in 26 Countries Across 10 World Regions: Results of the International Body Project I Hit paper breakdown → | 2010 | 545 |
| 3 | 2016 | 83 | |
| 4 | 2014 | 74 | |
| 5 | 2014 | 70 | |
| 6 | 2013 | 67 | |
| 7 | 2014 | 50 | |
| 8 | 2015 | 46 | |
| 9 | 2015 | 45 | |
| 10 | 2016 | 41 | |
| 11 | 2014 | 38 | |
| 12 | 2015 | 35 | |
| 13 | 2015 | 32 | |
| 14 | 2015 | 32 | |
| 15 | 2013 | 31 | |
| 16 | 2014 | 27 | |
| 17 | 2012 | 24 | |
| 18 | 2017 | 24 | |
| 19 | 2015 | 17 | |
| 20 | 2021 | 17 |
About Arvind Arora
Arvind Arora is a scholar working on Oncology, Surgery, Oral Surgery, Molecular Biology and Orthodontics, having authored 47 papers that have together received 2.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (15 papers), Cancer-related Molecular Pathways (6 papers), Hip disorders and treatments (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Genomics and Chromatin Dynamics (3 papers), Genetic factors in colorectal cancer (3 papers), Endodontics and Root Canal Treatments (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Pharmacy (124 citations), Oncology (541 citations), Clinical Psychology (411 citations), Cancer Research (199 citations) and Surgery (556 citations). Arvind Arora has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Srinivasan Madhusudan, Ian Ogilvie Ellis, Paul M. Moseley, Stephen Y.T. Chan, Graham Ball, Christina J. Perry, Andrew R. Green, Emad A. Rakha, Tarek M. A. Abdel-Fatah and Devika Agarwal. Their work appears in journals such as Molecular Oncology, Oncotarget, International Orthopaedics, Molecular Cancer Therapeutics and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.